@article{8f29a4f71f8449739eb524116a7cac20,
title = "The day after COVID-19 in IBD: how to go back to {\textquoteleft}normal{\textquoteright}",
author = "Silvio Danese and Bruce Sands and Ng, \{Siew C.\} and Laurent Peyrin-Biroulet",
note = "Funding Information: S.D. has served as a speaker, consultant and an advisory board member for Abbvie, Ferring, Hospira, Johnson \& Johnson, Merck, Millennium Takeda, Mundipharma, Pfizer, Tigenix, UCB Pharma and Vifor. B.S. has received financial support for research: Janssen, Takeda; consultancy: 4D Pharma, Abbvie, Allergan, Amgen, Arena Pharmaceuticals, Boehringer-Ingelheim, Capella Bioscience, Celgene, Celltrion Healthcare Co. Ltd., Ferring, Janssen, Lilly, Otsuka, Palatin Technologies, Pfizer, Progenity, Protagonist Therapeutics, Rheos Medicines, Salix Pharmaceuticals, Seres Therapeutics, Sienna Biopharmaceuticals, Takeda, Target PharmaSolutions, Therevance Biopharma R\&D and Vivelix Pharmaceuticals. S.C.N. has served as speaker for Janssen, Abbvie, Tillotts, Takeda, Olympus, Ferring. L.P.-B. has received consulting fees: Merck, AbbVie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillotts, Vifor, Therakos, Pharmacosmos, Pil{\`e}ge, BMS, UCB Pharma, Hospira, Celltrion, Takeda, Biogaran, Boerhinger Ingelheim, Lilly, Pfizer, HAC-Pharma, Index Pharmaceuticals, Amgen and Sandoz; lecture fees: Merck, AbbVie, Takeda, Janssen, Takeda, Ferring, Norgine, Tillots, Vifor, Therakos, Mitsubishi and HAC-Pharma.",
year = "2020",
month = aug,
day = "1",
doi = "10.1038/s41575-020-0322-8",
language = "English",
volume = "17",
pages = "441--443",
journal = "Nature Reviews Gastroenterology and Hepatology",
issn = "1759-5045",
publisher = "Nature Research",
number = "8",
}